News Update
Editorial Compares International Experiences in Risk-Benefit Analysis for Regulatory Decisions
In a guest editorial in Value in Health, Shelby Reed of Duke Clinical Research Institute and Gabriela Lavezzari of Duke-Margolis provide an overview of the international regulatory experience in quantitative risk-benefit analysis.
